CA
NZ
UK
AU
IND
US
…
Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery. It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Lexington, Kentucky.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Cardiff Lexington Corp is an OTC Pink–listed issuer trading as CDIX with limited public disclosure and no clear recent description of ongoing operations in readily available filings. Long-term growth drivers are uncertain given sparse reporting, though potential upside may depend on successful operational development, strategic asset acquisitions, or improved financial transparency, any of which could support investor interest if executed by management.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -6.54M | -3.19M | 3.11M | -1.43M | -1.43M |
| Net income | -6.54M | -3.30M | 3.03M | -4.65M | -0.41M |
| Selling general administrative | 6.09M | 4.61M | 3.08M | 3.73M | 4.52M |
| Gross profit | 7.21M | 4.43M | 8.29M | 6.16M | 6.16M |
| Reconciled depreciation | 0.01M | 0.01M | 0.02M | 0.02M | 0.04M |
| Ebit | - | -0.12M | 5.21M | 1.83M | 1.63M |
| Ebitda | 1.10M | -0.11M | 5.23M | 1.87M | 2.64M |
| Depreciation and amortization | - | 0.01M | 0.02M | 0.04M | - |
| Operating income | 1.10M | -0.19M | 5.20M | 1.83M | 1.63M |
| Other operating expenses | 9.66M | 8.46M | 6.66M | 8.38M | - |
| Interest expense | 6.82M | 3.07M | 2.09M | 4.03M | 4.03M |
| Net interest income | -6.82M | -3.07M | -2.09M | -6.65M | -4.03M |
| Income tax expense | - | -1.07M | 0.00M | 3.22M | - |
| Total revenue | 11.54M | 8.27M | 11.85M | 10.01M | 10.01M |
| Total operating expenses | 5.33M | 4.62M | 3.10M | 4.53M | 8.38M |
| Cost of revenue | 4.33M | 3.84M | 3.56M | 3.85M | 3.85M |
| Total other income expense net | -7.64M | -3.00M | -2.08M | -3.26M | 0.98M |
| Discontinued operations | - | - | - | 0.04M | 1.02M |
| Net income from continuing ops | -5.75M | -3.19M | 3.11M | -5.47M | -1.43M |
| Net income applicable to common shares | - | - | - | -5.43M | -0.41M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 29.09M | 23.93M | 20.75M | 11.16M | 11.16M |
| Other current assets | 0.20M | 0.09M | 0.01M | 0.01M | - |
| Total liab | 26.01M | 16.32M | 14.12M | 8.38M | 8.38M |
| Total stockholder equity | 5.54M | 7.60M | 6.62M | 2.78M | 2.78M |
| Other current liab | 7.11M | 6.14M | 6.89M | 0.47M | 0.50M |
| Common stock | 0.01M | 0.02M | 1.80M | 0.17M | 0.17M |
| Capital stock | 11.12M | 57.84M | 84.67M | 77.94M | 77.77M |
| Retained earnings | -79.49M | -72.95M | -68.68M | -66.19M | -66.19M |
| Good will | 5.67M | 5.67M | 5.67M | 4.48M | 4.48M |
| Other assets | - | - | - | 0.04M | 0.04M |
| Cash | 0.32M | 1.19M | 0.87M | 0.60M | 0.60M |
| Total current liabilities | 25.83M | 15.89M | 13.86M | 8.11M | 8.11M |
| Current deferred revenue | - | 0.15M | 0.01M | 4.76M | - |
| Net debt | 18.58M | 8.54M | 5.65M | 2.38M | 2.08M |
| Short term debt | 18.72M | 9.51M | 6.25M | 2.71M | - |
| Short long term debt | 18.54M | 9.06M | 5.94M | 3.57M | 2.54M |
| Short long term debt total | 18.90M | 9.72M | 6.51M | 2.98M | - |
| Other stockholder equity | 85.02M | 77.20M | - | -8.79M | -3.83M |
| Property plant equipment | - | - | - | 0.81M | 1.08M |
| Total current assets | 22.59M | 17.21M | 14.18M | 5.55M | 5.55M |
| Net tangible assets | - | - | - | -84.29M | -79.31M |
| Net receivables | 22.07M | 15.93M | 13.31M | 4.95M | 4.95M |
| Long term debt | 0.14M | 0.25M | 0.14M | 0.14M | 0.14M |
| Accounts payable | 1.09M | 0.68M | 0.72M | 0.17M | 0.17M |
| Accumulated other comprehensive income | - | - | -9.37M | - | - |
| Non currrent assets other | 0.61M | 0.08M | 0.03M | 0.04M | 0.04M |
| Non current assets total | 6.49M | 6.71M | 6.57M | 5.61M | 5.61M |
| Capital lease obligations | 0.22M | 0.41M | 0.28M | 0.23M | 0.30M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | - | - | 0.00M | -2.32M |
| Change to liabilities | - | - | - | 0.75M | -0.16M |
| Total cashflows from investing activities | - | - | - | - | -2.32M |
| Net borrowings | 2.03M | 3.20M | 2.37M | 0.87M | 0.88M |
| Total cash from financing activities | 1.98M | 2.98M | 2.37M | 3.68M | 3.68M |
| Change to operating activities | - | - | - | 1.29M | 0.48M |
| Net income | -5.51M | -3.30M | 3.11M | -0.41M | -0.41M |
| Change in cash | -0.87M | 0.32M | 0.65M | 0.32M | 0.32M |
| Begin period cash flow | 1.19M | 0.87M | 0.22M | 0.28M | 0.28M |
| End period cash flow | 0.32M | 1.19M | 0.87M | 0.60M | 0.60M |
| Total cash from operating activities | -2.85M | -2.65M | -1.72M | -1.04M | -1.04M |
| Issuance of capital stock | - | - | 0.00M | 0.03M | 3.00M |
| Depreciation | 0.01M | 0.01M | 0.02M | 0.04M | 0.04M |
| Dividends paid | 0.05M | 0.10M | 0.00M | -0.20M | -0.20M |
| Change to inventory | - | - | - | -0.24M | - |
| Change to account receivables | -6.40M | -4.55M | -6.70M | -1.10M | -1.10M |
| Sale purchase of stock | - | - | - | -0.03M | - |
| Other cashflows from financing activities | 2.03M | -0.12M | -0.00M | 3.99M | - |
| Change to netincome | - | - | - | 2.57M | -0.93M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | -5.16M | -4.98M | -4.91M | -0.78M | -0.78M |
| Stock based compensation | 0.75M | 0.54M | 0.03M | 0.87M | - |
| Other non cash items | 1.89M | 5.61M | 6.46M | 0.12M | 1.05M |
| Free cash flow | -2.85M | -2.65M | -1.72M | -1.04M | -1.04M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CDIX Cardiff Lexington Corp |
-0.01 28.00% |
0.02 | - | - | 1.97 | - | 4.49 | 47.87 |
| HCA HCA Healthcare, Inc. |
-3.77 0.80% |
465.26 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
0.50 0.19% |
268.95 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.11 0.83% |
13.02 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.09 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
Cardiff Lexington Corporation, through its subsidiaries, provides orthopedics, spine care, and pain management services in the United States. The company operates through two segments, Healthcare and Real Estate. The company provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves. It also engages in real estate business. The company also offers orthopedic and pain procedure services, including hip and knee replacement, shoulder reconstruction, fracture care, and hand surgery, as well as spinal surgery. It serves personal injury attorneys, insurance carriers, physical therapy providers, and chiropractic care providers. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation is based in Lexington, Kentucky.
710 East Main Street, Lexington, KY, United States, 40502
800-530-2100
15
| Name | Title | Year Born |
|---|---|---|
| Mr. Daniel R. Thompson | Chairman, Treasurer & Sec. | 1949 |
| Mr. Alex H. Cunningham | CEO, Pres & Director | 1956 |
| Mr. Steven M. Healy CPA | Chief Financial Officer | 1963 |
| Dr. Rollan Roberts II | COO & Sr. VP | 1979 |
| Mr. Daniel R. Thompson | Chairman of the Board & Secretary | 1949 |
| Mr. Alex H. Cunningham | CEO, President & Director | 1956 |
| Mr. Matthew T. Shafer CPA, M.B.A. | Senior VP, CFO, Chief Accounting Officer & Treasurer | 1971 |
| Dr. Kevin Fitzgerald M.D. | Managing Director of Nova Ortho & Spine | NA |
| Ms. Shannon Vitale | Controller | NA |
| Mr. Alex Hunt Cunningham | CEO, President & Chairman of the Board | 1956 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-0.43%
Communication Services
-0.70%
Consumer Cyclical
-0.35%
Consumer Defensive
-0.54%
Energy
+0.40%
Financial Services
-0.54%
Financials
+0.30%
Healthcare
+0.19%
Industrials
+0.38%
Real Estate
+0.22%
Technology
+0.27%
Utilities
-0.53%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...